0
Business
Here's Why Shares in Agios Pharmaceuticals Soared This Week (And What to Expect Next in 2026)
May 2, 2026
Scroll
Posted 2 hours ago by
The company faces competitive pressure from Novo Nordisk, but it's growing sales from its existing approved drugs and has an exciting drug in its pipeline.
The Motley Fool
Coverage and analysis from United States of America. All insights are generated by our AI narrative analysis engine.
United States of America
Bias: lean left
People's Voices (0)
Leave a comment
0/500
Note: Comments are moderated. Please keep it civil. Max 3 comments per day.